BDBM50314098 (3R,8R,11S,17S,20S,29S,32S,38aS)-8-[(2S)-2-[(2S)-2-{2-[({[(1S)-1-{[(1S)-1-{[(3R,8R,11S,17S,20S,29S,32S,38aS)-20-benzyl-3-carbamoyl-11-[(1R)-1-hydroxyethyl]-32-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-4-ylmethyl)-7,7,25,28-tetramethyl-29-(2-methylpropyl)-1,9,12,15,18,21,24,27,30,33,34-undecaoxo-hexatriacontahydropyrrolo[2,1-g]1,2-dithia-5,8,12,15,18,21,24,27,30,33-decaazacyclohexatriacontan-8-yl]carbamoyl}-2-phenylethyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}methyl)(methyl)amino]acetamido}-::CHEMBL1090636
SMILES: CC(C)C[C@@H]1N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN(C)CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](Cc3ccccc3)C(=O)NCC(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CSSC2(C)C)C(N)=O)C(C)(C)SSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)C(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(N)=O)[C@@H](C)O
InChI Key: InChIKey=FYNRYPLZXPBKDJ-MRJVFGEUSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IgG receptor FcRn large subunit p51 (Homo sapiens (Human)) | BDBM50314098 ((3R,8R,11S,17S,20S,29S,32S,38aS)-8-[(2S)-2-[(2S)-2...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Syntonix Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISA | J Med Chem 53: 1587-96 (2010) Article DOI: 10.1021/jm901128z BindingDB Entry DOI: 10.7270/Q23R0T1H | |||||||||||
More data for this Ligand-Target Pair |